US Bancorp
ORIC icon

US Bancorp’s Oric Pharmaceuticals ORIC Stock Holding History

US Bancorp’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-173
Closed -$2.19K – 4302
2026
Q1 		$2.19K Buy
+173
New +$1.96K ﹤0.01% 3785
2025
Q4 		– Sell
-34
Closed -$408 – 4165
2025
Q3 		$408 Buy
34
+6
+21% +$63 ﹤0.01% 3890
2025
Q2 		$284 Buy
28
+6
+27% +$40 ﹤0.01% 4046
2025
Q1 		$123 Sell
22
-5
-19% -$44 ﹤0.01% 4133
2024
Q4 		$218 Buy
+27
New +$248 ﹤0.01% 4076
2022
Q2 		– Sell
-69
Closed – – 4177
2022
Q1 		$0 Sell
69
-943
-93% -$8.49K ﹤0.01% 4165
2021
Q4 		$15K Sell
1,012
-343
-25% -$5.35K ﹤0.01% 3267
2021
Q3 		$28K Buy
+1,355
New +$27.5K ﹤0.01% 2949

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

US Bancorp's ORIC Position: Q2 2026 in Review

US Bancorp sold out of Oric Pharmaceuticals (ORIC) in Q2 2026, closing a stake of 173 shares — an estimated $2.19K sold.

US Bancorp first reported a position in ORIC in Q3 2021 and held it in 8 quarters. The position peaked at $28K in Q3 2021. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • US Bancorp reported no remaining Oric Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • US Bancorp sold 173 Oric Pharmaceuticals shares in Q2 2026, an estimated $2.19K.
  • US Bancorp first reported a position in Oric Pharmaceuticals in Q3 2021 and held it in 8 quarters.
  • US Bancorp's Oric Pharmaceuticals position peaked at $28K in Q3 2021.
  • 181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.